International Journal of Obstetrics and Gynecology

Objective To investigate the effective treatment of severe ovarian hyperstimulation syndrome (OHSS) complicated by pleuroperitoneal effusion after in vitro fertilization-embryo transfer (IVF-ET). Methods Sixty patients who came to our hospital from January 2021 to January 2023 were divided into group A, Group B and group C according to three stages of early, middle and late complications. Group A was treated with Wanwen, group B was treated with albumin combined with Wanwen, and group C was treated with a series of measures of early chest and abdominal suction. The results of the three groups were compared. Results In creatinine level, the data of group A, B and C after treatment were significantly better than before treatment, and the difference was significant (P<0.05); After treatment, the corresponding data of albumin and total protein levels in group B were better than those in group A and group C, and the difference was significant (P<0.05). In terms of hospital stay and treatment cost, there was little difference in the success rate of medical abortion between the observation group and the control group, and the comparison difference was not significant (P>0.05). Conclusion In patients with pleuroceliac effusion after OHSS of IVF-ET, active pleuroceliac effusion should be aspirated, and dilatation therapy should be taken according to the patients recovery. This treatment method can not only improve the complications, but also greatly reduce the patients hospital stay and treatment costs.

IVF-ET; OHSS; Pleuroperitoneal fluid; Clinical effect